Clinical Trial Update: Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neoadjuvant SBRT followed by nab-paclitaxel plus toripalimab in HR+/HER2- breast cancer is currently recruiting at Xijing Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Xijing Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING